Atlas Trials

Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome

Clinical trial NCT02117076 · TERMINATED

Trial details

NCT number
NCT02117076
Sponsor
Theresa Zesiewicz, MD
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Restless Leg Syndrome
Start date
2014-04-01
Primary completion
2016-06-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.